CALCIUM PHOSPHATE
Childhood Myelodysplastic Syndromes
Children's Oncology GroupSmall moleculePhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Childhood Myelodysplastic Syndromes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Children's Oncology Group | Phase 3 | BBB |
Cytosin-Arabinosid Children's Oncology Group | Phase 3 | BBB |
METHOTREXATE Children's Oncology Group | Phase 3 | BB |
CYCLOSPORIN A Fred Hutchinson Cancer Center | Phase 3 | BB |
ETOPOSIDE City of Hope Medical Center | Phase 3 | BB |
View all 34 →
Same molecule, other indications
CALCIUM PHOSPHATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →